Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do low-molecular-weight heparins improve the survival of cancer patients?

Nature Clinical Practice Oncology volume 2, pages 612–613 (2005)Cite this article

boxed-textLee AYY et al. (2005) Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 23: 2123–2129

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kakkar AK et al. (2004) Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol 22: 1944–1948

    Article  CAS  Google Scholar 

  2. Klerk CP et al. (2005) The effect of low-molecular-weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23: 2130–2135

    Article  CAS  Google Scholar 

  3. Altimbas M et al. (2004) A randomized clinical trial of combination chemotherapy with and without low molecular weight heparin in small cell lung cancer. J Thromb Haemost 2: 1266–1271

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. M Di Nisio is a PhD student, and E Porreca is an Associate Professor at the Department of Internal Medicine, “Gabriele D'Annunzio” University, Chieti, Italy

    Marcello Di Nisio & Ettore Porreca

  2. Professor and Head of the Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

    Harry R Buller

Authors
  1. Marcello Di Nisio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harry R Buller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ettore Porreca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcello Di Nisio.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Nisio, M., Buller, H. & Porreca, E. Do low-molecular-weight heparins improve the survival of cancer patients?. Nat Rev Clin Oncol 2, 612–613 (2005). https://doi.org/10.1038/ncponc0329

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0329

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing